Pharmaceuticals IMBRUVICA Accelerated Approvals for Lymphoma Indications UpdateBy AndyApril 10, 2023 Update on IMBRUVICA (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications The Janssen Pharmaceutical Companies…